A detailed history of Farther Finance Advisors, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 40 shares of PGEN stock, worth $166. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Holding current value
$166
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$1.43 - $4.76 $57 - $190
40 New
40 $132,000
Q4 2023

Feb 14, 2024

BUY
$0.89 - $1.41 $69 - $109
78 New
78 $105,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $866M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.